ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility

ProBio's landmark facility seeks to transform plasmid and viral-vector production

ProBio's landmark facility seeks to transform plasmid and viral-vector production at new site in Hopewell

ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility

ProBio, a CDMO and subsidiary of GenScript Biotech, opened its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, NJ. The 128,000-sq-ft GMP facility is purpose-built for manufacturing plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms. “This is not just a new facility. It is a beacon of hope for patients waiting for cures,” said Allen G…

ProBio opens cell, gene therapy hub in Hopewell

A global leader in cell and gene therapy manufacturing recently planted its flag here in the Garden State. ProBio cut the ribbon on its new flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell June 27. A number of company leaders, government officials, life sciences stakeholders and more were on-hand for the ribbon cutting. “This is not just a new facility,” said ProBio CEO Allen Guo. “It is a b…